Mirae Asset Global Investments Co., Ltd. Olema Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $54.3 Billion
- Q1 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 10,539 shares of OLMA stock, worth $150,813. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,539
Previous 15,951
33.93%
Holding current value
$150,813
Previous $223,000
46.64%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding OLMA
# of Institutions
132Shares Held
56.1MCall Options Held
55KPut Options Held
41.3K-
Bvf Inc San Francisco, CA9.14MShares$131 Million3.1% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.9MShares$113 Million3.36% of portfolio
-
Logos Global Management LP San Francisco, CA4.38MShares$62.7 Million4.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.23MShares$46.2 Million1.21% of portfolio
-
Black Rock Inc. New York, NY3.22MShares$46 Million0.0% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $578M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...